Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X MSCI Argentina ETF (ARGT) vs Medpace Holdings Inc (MEDP) Price & Performance

Global X MSCI Argentina ETFTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Global X MSCI Argentina ETF vs Medpace Holdings Inc — how do they compare? Global X MSCI Argentina ETF trades at $91.52, while Medpace Holdings Inc trades at $598.64 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Global X MSCI Argentina ETF nearer its low. Which is the better fit depends on your goals.

ARGTMEDP
Sector
Broad Market / FactorTechnology
52-Week High
$102.94$620.59
52-Week Low
$67.55$393.42
Market Cap
$16.90B
Enterprise Value
$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X MSCI Argentina ETF

ARGT is trading at $91.95, down 1.58% today amid bearish technical signals. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $92. Recent Seeking Alpha analysis (June 18, 2026) highlights Argentina's economic reforms creating potential for 28% upside, though financial ratios remain undisclosed. The fund's concentration in MercadoLibre presents both opportunity and risk as Argentina's monetary backdrop improves.

The outlook suggests cautious optimism with reform progress driving potential re-rating, though technical weakness and single-country concentration require careful risk management. Near-term performance hinges on Argentina's economic stabilization and institutional investor confidence, with Stanley Druckenmiller's recent position (Q1 2026) indicating sophisticated investor interest.

Medpace Holdings Inc

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X MSCI Argentina ETF

ARGT seeks to provide investment results that correspond to the performance of the MSCI All Argentina 25/50 Index. It offers targeted exposure to some of the largest and most liquid companies operating in Argentina.

Read more on ARGT

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP